BeiGene Ltd
Biotechnology
Healthcare
BGNE
106 M shares
NASDAQ US
traded
31 Dec 2024
listed
no
open
184.00
52 week high
246.04
high
187.42
52 week low
129.52
previous Close
183.81
P/E ratio
-161
market cap
19.86 B
div yield
0
net incoming
-121.35 M
-0.78 %
net profit margin
-12.12 %
0.00 %
operating incoming
-120.27 M
-12.23 %
net change in cash
95.50 M
150.39 %
cash on hand
2.70 B
4.21 %
cost of revenue
170 M
23.41 %
top